Xylocain (lidocaine Hcl ) Injection, Solution
Product Images NDC 51662-1587

11 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Xylocain (lidocaine Hcl ) (NDC 51662-1587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1587 2 Pouch Label)

Pouch Labeling (51662 1587 2 Pouch Label)
XYLOCAINE (LIDOCAINE HCl) Injection 1% 10 mg/mL in a 50 mL vial. The label displays the product name, strength, dosage form, volume, lot number, and expiration date. It is labeled for infiltration and nerve block use, not for caudal or epidural use. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*
FDA Label Image

Case Labeling (51662 1587 3 Case Label)

Case Labeling (51662 1587 3 Case Label)
Label for XYLOCAINE (LIDOCAINE HCl) Injection USP 1% 500 mg/50 mL (10 mg/mL) in a 50 mL vial, packaged as a case of 25. The label includes the NDC 51662-1587-3, lot number, and expiration date. It notes use for infiltration and nerve block, not for caudal or epidural use, and is manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*
FDA Label Image

Rfid Labeling (51662 1587 3 Rfid Label)

Rfid Labeling (51662 1587 3 Rfid Label)
A small white rectangular pharmacy label with a barcode and text indicating distribution by HF Acquisition Co LLC, located in Mukilteo, WA. The label instructs to see the manufacturer's package insert and includes a notation for RX only. The label is affixed to a transparent resealable plastic bag.*
FDA Label Image

Hs1 (Hs 1)

Hs1 (Hs 1)
Two tables listing NDC product codes, unit sizes, strength percentages or mg per mL, and packaging details for XYLOCAIN (LIDOCAINE HCl) Injection, USP and XYLOCAINE -HPB (LIDOCAINE HCl) Injection, USP. The tables display various formulations, including multi-dose and single-dose vial presentations with corresponding strengths ranging from 0.5% to 10 mg/mL, and unit of sale information such as 25 or 50 mL vials.*
FDA Label Image
Logo (Hs Logo)
XYLOCAIN (LIDOCAINE HCl) 10 mg/mL Injection, Solution carton. The box features the brand name XYLOCAIN prominently along with the active ingredient lidocaine hydrochloride. It includes 20 mL single-dose vials. The label also shows the labeler HF Acquisition Co LLC, DBA HealthFirst, and product NDC 51662-1587. The packaging includes dosage route information for infiltration and perineural use.*
FDA Label Image

Hs2 (Hs2)

Hs2 (Hs2)
A data table listing various strengths, units of sale, and packaging details for Xylocaine (lidocaine HCl) and epinephrine injection formulations. It includes NDC codes, concentrations in percent and mg per mL, and the sizes of multiple-dose and single-dose vials available from HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Max Dosage (Maximum Reco Dosage)

Max Dosage (Maximum Reco Dosage)
A data table listing dosages for XYLOCAIN (LIDOCAINE HCl) injection, solution 10 mg/mL by various routes including infiltration and perineural. The table includes columns for procedure, volume (mL), concentration, and total dose (mg), with detailed entries for different anesthesia types and administration sites.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A table presenting drug classes and examples. It includes classes like Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs with specific example drugs listed for each class.*
FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure of lidocaine hydrochloride showing the aromatic ring with methyl groups, the amide linkage, and diethylamino functional group associated with the hydrochloride salt.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure diagram of lidocaine hydrochloride, the active ingredient in XYLOCAIN injection solution 10 mg/mL. The structure displays a benzene ring with hydroxyl groups and an amine side chain.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for Xylocaine (Lidocaine HCl Injection, USP) 1% solution, containing 500 mg per 50 mL (10 mg/mL) in a 50 mL multiple dose vial. The label indicates use for infiltration and nerve block, with a caution against caudal or epidural use. It includes storage instructions, manufacturer information for Fresenius Kabi, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.